DMAQ
Income statement / Annual
Last year (2024), Deep Medicine Acquisition Corp.'s total revenue was $21.86 M,
and the percentage change from the previous year is not available.
In 2024, Deep Medicine Acquisition Corp.'s net income was -$8.80 M.
See Deep Medicine Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
03/31/2023 |
03/31/2022 |
| Operating Revenue |
$21.86 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$7.27 M
|
$60.00 K
|
$60.00 K
|
| Gross Profit |
$14.59 M
|
-$60.00 K
|
-$60.00 K
|
| Gross Profit Ratio |
0.67
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$1.91 M
|
$409.91 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.67 M
|
$1.91 M
|
$409.91 K
|
| Other Expenses |
$2.75 M
|
$200.00 K
|
$60.00 K
|
| Operating Expenses |
$9.42 M
|
$2.11 M
|
$409.91 K
|
| Cost And Expenses |
$16.69 M
|
$2.17 M
|
$409.91 K
|
| Interest Income |
$106.40 K
|
$0.00
|
$0.00
|
| Interest Expense |
-$6.93 M
|
$0.00
|
$8.27 K
|
| Depreciation & Amortization |
$0.00
|
-$3.65 M
|
$55.87 K
|
| EBITDA |
-$2.10 M |
-$3.99 M |
-$349.91 K |
| EBITDA Ratio |
-0.1
|
0
|
0
|
| Operating Income Ratio |
-0.1
|
0
|
0
|
| Total Other Income/Expenses Net |
-$6.69 M
|
$1.88 M
|
$47.60 K
|
| Income Before Tax |
-$8.80 M
|
-$342.66 K
|
-$414.05 K
|
| Income Before Tax Ratio |
-0.4
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$57.57 K
|
-$55.87 K
|
| Net Income |
-$8.80 M
|
-$400.23 K
|
-$358.18 K
|
| Net Income Ratio |
-0.4
|
0
|
0
|
| EPS |
-756.01 |
-0.17 |
-0.041 |
| EPS Diluted |
-0.76 |
-0.04 |
-0.041 |
| Weighted Average Shares Out |
$11.63 M
|
$2.31 M
|
$8.74 M
|
| Weighted Average Shares Out Diluted |
$11.63 M
|
$10.00 M
|
$8.74 M
|
| Link |
|
|
|
